Clinical Trial: Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Underg
Brief Summary: Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)
Detailed Summary:
Sponsor: Santen Inc.
Current Primary Outcome: Concentration of levofloxacin and moxifloxacin in the corneal tissue [ Time Frame: Time of surgery ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Adverse Events [ Time Frame: 4 days ]
Original Secondary Outcome: Same as current
Information By: Santen Inc.
Dates:
Date Received: September 26, 2008
Date Started: September 2008
Date Completion:
Last Updated: August 24, 2009
Last Verified: August 2009